Latest Dorsavi (ASX:DVL) News

Robotics, AI chips and defence software drove the week’s biggest technology moves, but not every early jump held. Investors chased clear revenue growth and contract wins, while cash pressure and equity raisings kept a lid on parts of the sector.

dorsaVi has launched a multi-year partnership with Taiwan’s ITRI and NTU to develop its proprietary RRAM platform at the 22-nm node, complemented by a new advisory board and neuromorphic IP acquisition, positioning the company at the forefront of ultra-edge AI hardware.

dorsaVi is pivoting from wearable sensors to powering next-gen exoskeletons, leveraging its neuromorphic RRAM technology to tap a projected $2 billion market by 2033.

Speculative tech names drove the biggest swings this week, while data centres and software groups kept tapping investors for growth capital. The clearest pattern was simple: companies that showed revenue, contracts or cash support were rewarded, but some early price jumps faded fast when buyers stepped back.

dorsaVi has confirmed that its proprietary RRAM memory technology and neuromorphic IP portfolio work seamlessly together, projecting a tenfold boost in performance for robotics and exoskeleton applications. This breakthrough lays the groundwork for smarter, faster, and more energy-efficient wearable and robotic devices operating at the ultra-edge.

A small-cap tech week where one US gaming platform build lit the fuse, while a big semiconductor raise kept sliding after the halt. Deals and contracts did the heavy lifting, but several “open higher, finish lower” sessions showed buyers are still picky.

dorsaVi has commenced development of Sensor V6.5, a firmware upgrade that embeds intelligence directly within its wearable sensors, reducing latency and paving the way for future neuromorphic computing integration.

A brutal split opened up in small caps: a few stocks surged on hard approvals and funding, while many resource names slid even after announcing big numbers. The week’s tape looked simple: investors paid for certainty and sold anything that still needs time, permits, or more cash.

dorsaVi has secured significant commercial and clinical milestones with new elite sports and European clinical partnerships, showcasing its advanced real-time AI sensor technology.

Tech microcaps swung hard as funding news, contract wins and disclosure issues collided. The biggest falls came where investors saw either forced selling or more cash needs ahead.

dorsaVi has initiated early-stage evaluation of resistive RAM (RRAM) test chips, marking a key step toward an advanced 22-nm memory platform designed to meet rising AI-driven demands in edge computing.

A single trading halt lit a fire under one small-cap, while a string of fundraisings reminded investors how often growth still needs fresh cash. Elsewhere, “AI-first” is splitting into two camps: products that ship now, and stories that still need proof.